loading
Cyclerion Therapeutics Inc stock is traded at $2.41, with a volume of 3,595. It is down -2.03% in the last 24 hours and up +2.34% over the past month. Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$2.46
Open:
$2.46
24h Volume:
3,595
Relative Volume:
0.10
Market Cap:
$8.18M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-1.1262
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
+6.64%
1M Performance:
+2.34%
6M Performance:
-4.74%
1Y Performance:
-16.90%
1-Day Range:
Value
$2.45
$2.46
1-Week Range:
Value
$2.30
$2.62
52-Week Range:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Name
Cyclerion Therapeutics Inc
Name
Phone
617-621-7722
Name
Address
301 BINNEY STREET, CAMBRIDGE, MA
Name
Employee
1
Name
Twitter
@Cyclerion
Name
Next Earnings Date
2024-12-15
Name
Latest SEC Filings
Name
CYCN's Discussions on Twitter

Compare CYCN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
2.45 7.88M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
393.56 101.15B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.51 61.07B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
566.05 59.35B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
746.27 46.29B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.77 35.69B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-21 Initiated Truist Buy
Sep-24-21 Initiated Cantor Fitzgerald Overweight
Jun-03-19 Initiated Credit Suisse Neutral

Cyclerion Therapeutics Inc Stock (CYCN) Latest News

pulisher
07:10 AM

Using economic indicators to assess Cyclerion Therapeutics Inc. potential2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com

07:10 AM
pulisher
06:10 AM

Best data tools to analyze Cyclerion Therapeutics Inc. stockWeekly Profit Analysis & Reliable Volume Spike Alerts - newser.com

06:10 AM
pulisher
04:03 AM

Strategies to average down on Cyclerion Therapeutics Inc.2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com

04:03 AM
pulisher
02:36 AM

Is this a good reentry point in Cyclerion Therapeutics Inc.Weekly Gains Report & AI Driven Price Forecasts - newser.com

02:36 AM
pulisher
01:07 AM

Full technical analysis of Cyclerion Therapeutics Inc. stockJuly 2025 Drop Watch & Accurate Buy Signal Alerts - newser.com

01:07 AM
pulisher
Sep 14, 2025

Using RSI to spot recovery in Cyclerion Therapeutics Inc.July 2025 Opening Moves & Safe Entry Zone Tips - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will Cyclerion Therapeutics Inc. bounce back from current supportJuly 2025 Gainers & Verified Technical Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

What MACD signals say about Cyclerion Therapeutics Inc.Jobs Report & Momentum Based Trading Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Exit strategy if you’re trapped in Cyclerion Therapeutics Inc.Day Trade & Technical Pattern Based Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will Cyclerion Therapeutics Inc. stock recover after recent dropWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Will Cyclerion Therapeutics Inc. price bounce be sustainableMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

will cyclerion therapeutics inc. stock recover after recent dropVolume Spike & Weekly High Momentum Picks - newser.com

Sep 14, 2025
pulisher
Sep 12, 2025

Cyclerion Therapeutics Inc.’s volatility index tracking explained2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Cyclerion Therapeutics Inc. stock retracement – recovery analysisWeekly Investment Report & Weekly High Conviction Ideas - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Long term hold vs stop loss in Cyclerion Therapeutics Inc.Inflation Watch & Weekly Stock Performance Updates - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Signal strength of Cyclerion Therapeutics Inc. stock in tech scannersEarnings Trend Report & Weekly Breakout Watchlists - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Chart based analysis of Cyclerion Therapeutics Inc. trendsPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Custom strategy builders for tracking Cyclerion Therapeutics Inc.Insider Buying & Breakout Confirmation Trade Signals - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is Cyclerion Therapeutics Inc. trending in predictive chart modelsJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Using Python tools to backtest Cyclerion Therapeutics Inc. strategiesTrade Analysis Report & Short-Term Trading Opportunity Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Applying Wyckoff theory to Cyclerion Therapeutics Inc. stockJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Is a relief rally coming for Cyclerion Therapeutics Inc. holders2025 Major Catalysts & Daily Stock Trend Reports - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Does Cyclerion Therapeutics Inc. qualify in momentum factor screening2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - Newser

Sep 12, 2025
pulisher
Sep 12, 2025

Can volume confirm reversal in Cyclerion Therapeutics Inc.July 2025 PostEarnings & Stepwise Swing Trade Plans - Newser

Sep 12, 2025
pulisher
Sep 11, 2025

Cyclerion Therapeutics Inc. stock outlook for YEARMarket Activity Recap & Precise Entry and Exit Recommendations - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Analyzing Cyclerion Therapeutics Inc. with multi timeframe charts2025 Short Interest & Intraday High Probability Setup Alerts - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

Forecasting Cyclerion Therapeutics Inc. price range with options dataQuarterly Profit Review & Consistent Profit Trading Strategies - Newser

Sep 11, 2025
pulisher
Sep 11, 2025

cyclerion therapeutics inc.’s volatility index tracking explainedJuly 2025 Closing Moves & Safe Entry Point Identification - Newser

Sep 11, 2025
pulisher
Sep 10, 2025

Chart based exit strategy for Cyclerion Therapeutics Inc.Trade Exit Report & Verified Short-Term Trading Plans - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Understanding Cyclerion Therapeutics Inc.’s price movement2025 Earnings Impact & Consistent Return Investment Signals - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Candlestick signals on Cyclerion Therapeutics Inc. stock today2025 Market Overview & Fast Moving Stock Watchlists - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Is Cyclerion Therapeutics Inc. forming a reversal patternJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Can Cyclerion Therapeutics Inc. recover in the next quarterPortfolio Value Summary & Stepwise Swing Trade Plans - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

How to forecast Cyclerion Therapeutics Inc. trends using time seriesJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Backtesting results for Cyclerion Therapeutics Inc. trading strategiesWeekly Investment Summary & Fast Entry High Yield Stock Tips - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Analyzing net buyer seller activity in Cyclerion Therapeutics Inc. - Newser

Sep 10, 2025
pulisher
Sep 10, 2025

Using data tools to time your Cyclerion Therapeutics Inc. exitWeekly Trend Report & Technical Entry and Exit Tips - Newser

Sep 10, 2025

Cyclerion Therapeutics Inc Stock (CYCN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$35.82
price down icon 1.13%
$83.25
price down icon 0.06%
$28.01
price up icon 0.65%
$97.68
price up icon 1.01%
$145.07
price down icon 0.60%
biotechnology ONC
$332.98
price up icon 2.74%
Cap:     |  Volume (24h):